Uterocutaneous fistula managed medically: A case report.

Authors

DOI:

https://doi.org/10.29052/IJEHSR.v11.i2.2023.104-109

Keywords:

Laparotomy, Uterocutaneous Fistula, Myomectomy, Septic Abortion, GnRH Agonists.

Abstract

Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment.

Case Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar.

Management: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle.

Conclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.

 

Downloads

Published

2023-03-28

How to Cite

Koulshan Mustafa, Gul-e-rana Abdul, Rabiya Niaz, Durr-e-shahwar Hayat, & Sultan , A. (2023). Uterocutaneous fistula managed medically: A case report. International Journal of Endorsing Health Science Research, 11(2), 104–109. https://doi.org/10.29052/IJEHSR.v11.i2.2023.104-109